1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Dan Blazer III, M.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies Talimogene Laherparepvec - Peritoneal Surface Malignancy | Phase 1 | Completed | Dan Blazer III, M.D. | 28 | 2019-05-23 | 2024-11-20 |
United States (1)
Dan Blazer, MD (1) · John H Stewart, MD (1)